Articles tagged with Nanomedicine
The University of Copenhagen has received funding to establish a new center for pharmaceutical nanotechnology and nanotoxicology, aiming to optimize delivery systems and therapeutic benefits. The center will focus on rational design of nanotechnology materials and tools to improve therapeutic benefit-to-risk ratio.
The Mattel UCLA NanoPediatrics Program will explore the future of personalized medicine for children using nanotechnology. Researchers will develop new diagnostic tools and treatments to improve health outcomes for young patients.
Researchers developed a multistage delivery system to improve injectable drug efficacy, targeting diseased cells and releasing therapeutics in a controlled manner. The system uses mesoporous silicon particles to circumvent biobarriers and deliver diagnostic agents or therapeutic agents.
Researchers at UT Health Science Center have developed a smart particle insulin release system that detects blood sugar spikes and releases insulin to counteract them. The system, which consists of a blood sugar sensing protein and liposomes loaded with insulin, stabilized blood sugar levels in animal models for up to six hours.
Purdue University has been awarded $7 million to study the use of a nanomotor, a microscopic biological machine, for diagnosing and treating diseases like cancer and AIDS. The team will adapt a viral motor to package therapeutic DNA or RNA for disease-causing cells.
The new center will apply advanced engineering techniques and life science knowledge to control molecular interactions in cells, aiming to enhance disease treatment methods. Researchers will investigate optimal drug cocktails and mapping of molecular events that trigger stem cell differentiation.
A $6.5 million nanomedicine center at Yale University aims to design, model, synthesize, and fabricate nanomedical devices based on natural and synthetic ion transporters. The center will focus on developing biobatteries for implantable devices, including an artificial retina.
Researchers are developing functional nanoparticles that can be linked to biological molecules, enabling rapid analysis of biopsy tissue from cancer patients. These nanoprobes using quantum dots can monitor the effectiveness of drug therapy and deliver controlled amounts of drugs into genetically classified tumor cells.
The Lancet calls for increased investment in nanomedicine research, citing its potential to revolutionize disease diagnosis and treatment. The field's benefits include novel means of imaging and delivery systems for drugs and gene therapies.